Index by author

September 1, 2022; Volume 50,Issue 3

  1. Tanwar, Karan Singh

    1. Radioiodine Therapy in Patient with Differentiated Thyroid Cancer and End-Stage Renal Disease on Maintenance Hemodialysis: Case Report with Review of Literature
      Radioiodine Therapy in Patient with Differentiated Thyroid Cancer and End-Stage Renal Disease on Maintenance Hemodialysis: Case Report with Review of Literature
      Munish Kumar, Karthikeyan Subramanian, Karan Singh Tanwar, Arun Prabhahar, Smita Divyaveer, Ashwani Sood, Bhagwant Rai Mittal and Apurva Sood
      Journal of Nuclear Medicine Technology September 1, 2022, 50 (3) 228-232; DOI: https://doi.org/10.2967/jnmt.121.261979

  2. Tempesta, Daniel

    1. 177Lu-Vipivotide Tetraxetan (177Lu-PSMA-617, Pluvicto) Therapy
      Sarah Clements, Daniel Tempesta and Heather Jacene
      Journal of Nuclear Medicine Technology September 1, 2022, 50 (3) 213-214; DOI: https://doi.org/10.2967/jnmt.122.264731
    2. 223Ra-Dichloride Therapy
      Sarah Clements, Daniel Tempesta and Matthew Robertson
      Journal of Nuclear Medicine Technology September 1, 2022, 50 (3) 222-223; DOI: https://doi.org/10.2967/jnmt.122.264765

  3. Thomas, Kathy S.

    1. Theranostics: The Future is Now!
      Kathy S. Thomas
      Journal of Nuclear Medicine Technology September 1, 2022, 50 (3) 185;

  4. Tipnis, Sameer

    1. Risk of Radiation Exposure to Clinical Staff from Paracenteses of Large-Volume Chylous Ascites After <sup>177</sup>Lu-DOTATATE Infusion
      Risk of Radiation Exposure to Clinical Staff from Paracenteses of Large-Volume Chylous Ascites After 177Lu-DOTATATE Infusion
      Sameer Tipnis, William J. Rieter, Vladimir Henderson-Suite and Leonie Gordon
      Journal of Nuclear Medicine Technology September 1, 2022, 50 (3) 274-277; DOI: https://doi.org/10.2967/jnmt.121.262820

  5. Trifunovic, Marko

    1. <sup>18</sup>F-DCFPyL PET/CT in Metastatic Renal Cell Carcinoma
      18F-DCFPyL PET/CT in Metastatic Renal Cell Carcinoma
      Geoffrey M. Currie, Marko Trifunovic, Jui Liu, Sang Kim and Howard Gurney
      Journal of Nuclear Medicine Technology September 1, 2022, 50 (3) 282-285; DOI: https://doi.org/10.2967/jnmt.121.262799

  6. Vohra, Mehak

    1. <sup>68</sup>Ga-Pentixafor PET/CT Demonstrating In Vivo CXCR4 Receptor Overexpression in Rare Lung Malignancies: Correlation with Histologic and Histochemical Findings
      68Ga-Pentixafor PET/CT Demonstrating In Vivo CXCR4 Receptor Overexpression in Rare Lung Malignancies: Correlation with Histologic and Histochemical Findings
      Ankit Watts, Baljinder Singh, Harmandeep Singh, Harneet Kaur, Amanjit Bal, Mehak Vohra, Sunil K. Arora and D. Behera
      Journal of Nuclear Medicine Technology September 1, 2022, 50 (3) 278-281; DOI: https://doi.org/10.2967/jnmt.122.264141

  7. Vyas, Madhusudan

    1. Stability Matters: Radiochemical Stability of Therapeutic Radiopharmaceutical <sup>177</sup>Lu-PSMA I&amp;T
      Stability Matters: Radiochemical Stability of Therapeutic Radiopharmaceutical 177Lu-PSMA I&T
      Madhusudan Vyas, Remy Lim, Jessica Fagan and Rudresh Chandrashekar
      Journal of Nuclear Medicine Technology September 1, 2022, 50 (3) 244-247; DOI: https://doi.org/10.2967/jnmt.121.262423

  8. Watts, Ankit

    1. <sup>68</sup>Ga-Pentixafor PET/CT Demonstrating In Vivo CXCR4 Receptor Overexpression in Rare Lung Malignancies: Correlation with Histologic and Histochemical Findings
      68Ga-Pentixafor PET/CT Demonstrating In Vivo CXCR4 Receptor Overexpression in Rare Lung Malignancies: Correlation with Histologic and Histochemical Findings
      Ankit Watts, Baljinder Singh, Harmandeep Singh, Harneet Kaur, Amanjit Bal, Mehak Vohra, Sunil K. Arora and D. Behera
      Journal of Nuclear Medicine Technology September 1, 2022, 50 (3) 278-281; DOI: https://doi.org/10.2967/jnmt.122.264141
« Previous (Pages : 7 8 9 10 11 ... 11)next »
Back to top

In this issue

We use cookies on this site to enhance your user experience

By clicking any link on this page you are giving your consent for us to set cookies.